Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ulnar artery aneurysm in a patient with Behçet's disease.
Kisacik B, Kasifoglu T, Akay S, Yilmaz O, Yilmaz S, Simsek I, Erdem H, Pay S, Dinc A. Kisacik B, et al. Among authors: kasifoglu t. Rheumatol Int. 2010 Jan;30(3):383-5. doi: 10.1007/s00296-009-0951-2. Epub 2009 May 20. Rheumatol Int. 2010. PMID: 19455338
Risk factors for malignancy in systemic sclerosis patients.
Kaşifoğlu T, Yaşar Bilge Ş, Yıldız F, Özen G, Pehlivan Y, Yılmaz N, Tarhan F, Yılmaz S, Küçük A, Emmungil H, Koca SS, Çınar M, Direskeneli H, Erken E, Can G, Özmen M, Gönüllü E, Kisacik B, Aksu K, Karadağ O, Kasifoglu N, Arslantas D, Sahin F, Keser G, Yavuz S, Birlik M, Onat AM. Kaşifoğlu T, et al. Among authors: kasifoglu n. Clin Rheumatol. 2016 Jun;35(6):1529-33. doi: 10.1007/s10067-016-3288-8. Epub 2016 Apr 27. Clin Rheumatol. 2016. PMID: 27118199
Predictive factors for work-day loss in Behçet's syndrome: A multi-center study.
Mumcu G, Yay M, Aksoy A, Taş MN, Armağan B, Sarı A, Bozca BC, Tekgöz E, Karadağ DT, Badak SÖ, Tecer D, Bes C, Şahin A, Erken E, Cefle A, Çınar M, Yılmaz S, Karaçaylı Ü, Alpsoy E, Şenel S, Yaşar Bilge Ş, Kaşifoğlu T, Karadağ Ö, Aksu K, Keser G, Alibaz-Öner F, İnanç N, Ergun T, Direskeneli H. Mumcu G, et al. Among authors: kasifoglu t. Int J Rheum Dis. 2020 Feb;23(2):240-246. doi: 10.1111/1756-185X.13771. Epub 2019 Dec 19. Int J Rheum Dis. 2020. PMID: 31858715
Moderation analysis exploring associations between age and mucocutaneous activity in Behçet's syndrome: A multicenter study from Turkey.
Mumcu G, Yay M, Karaçaylı Ü, Aksoy A, Taş MN, Armağan B, Sarı A, Bozca BC, Tekgöz E, Temiz Karadağ D, Badak SÖ, Tecer D, Yıldırım A, Bes C, Şahin A, Erken E, Cefle A, Çınar M, Yılmaz S, Alpsoy E, Boyvat A, Şenel S, Bilge ŞY, Kaşifoğlu T, Karadağ Ö, Aksu K, Keser G, Alibaz-Öner F, İnanç N, Ergun T, Direskeneli H. Mumcu G, et al. Among authors: kasifoglu t. J Dermatol. 2020 Dec;47(12):1403-1410. doi: 10.1111/1346-8138.15553. Epub 2020 Sep 27. J Dermatol. 2020. PMID: 32981075
Association of disease characteristics with the temporal sequence of skin and musculoskeletal disease onset in psoriatic arthritis.
Tascilar K, Bayindir O, Dogru A, Tinazzi I, Kimyon G, Ozisler C, Erden A, Dalkilic E, Cetin GY, Yılmaz S, Solmaz D, Bakirci S, Omma A, Kasifoglu T, Kucuksahin O, Cinar M, Kilic L, Can M, Tarhan EF, Bilgin E, Ersozlu ED, Duruoz T, Yavuz S, Pehlevan S, Tufan MA, Gonullu E, Yildiz F, Esmen SE, Kucuk A, Tufan A, Balkarli A, Mercan R, Yazisiz V, Erten S, Akar S, Aksu K, Aydin SZ, Kalyoncu U. Tascilar K, et al. Among authors: kasifoglu t. Br J Dermatol. 2021 Jun;184(6):1202-1203. doi: 10.1111/bjd.19826. Epub 2021 Apr 25. Br J Dermatol. 2021. PMID: 33481249 No abstract available.
The prevalence of non-vascular pulmonary manifestations in Takayasu's Arteritis patients: A Retrospective multi-centred Turkish cohort study.
Yazici A, Kaymaz-Tahra S, Ozdemir Isik O, Kara M, Alpay-Kanitez N, Gerçik O, Omma A, Kocaer SB, Kalkan K, Yasar Bilgin NS, Aksu K, Keser G, Akar S, Onen F, Emmungil H, Kasifoglu T, Alibaz-Oner F, Direskeneli H, Cefle A. Yazici A, et al. Among authors: kasifoglu t. Scand J Rheumatol. 2022 Jul;51(4):304-308. doi: 10.1080/03009742.2021.1972535. Epub 2021 Oct 13. Scand J Rheumatol. 2022. PMID: 34643164
Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?
İlgen U, Karadağ Ö, Emmungil H, Küçükşahin O, Koca SS, Erden A, Bes C, Alpay Kanıtez N, Dalkılıç E, Akar S, Mercan R, Çınar M, Kaşifoğlu T, Gönüllü E, Kimyon G, Ersözlü D, Atagündüz P, Kılıç L, Ertenli İ, Yazısız V, Ateş A, Kiraz S, Kalyoncu U. İlgen U, et al. Among authors: kasifoglu t. Rheumatol Int. 2022 Oct;42(10):1797-1806. doi: 10.1007/s00296-022-05134-z. Epub 2022 Apr 29. Rheumatol Int. 2022. PMID: 35486197
The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database.
Alpay Kanıtez N, Kiraz S, Dalkılıç E, Kimyon G, Mercan R, Karadağ Ö, Bes C, Kılıç L, Akar S, Ateş A, Emmungil H, Ertenli İ, Pehlivan Y, Coşkun BN, Yağız B, Ersözlü D, Gönüllü E, Çınar M, Kaşifoğlu T, Koca SS, Karasu U, Küçükşahin O, Kalyoncu U. Alpay Kanıtez N, et al. Among authors: kasifoglu t. Eur J Rheumatol. 2022 Oct;9(4):206-211. doi: 10.5152/eurjrheum.2022.21153. Eur J Rheumatol. 2022. PMID: 36650959 Free PMC article.
135 results